Greenwich LifeSciences, Inc.
GLSI · XNASCIK 1799788fmd_0SAF208GCYH6SBW6SMWBXVEDGBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Jun 30, 2026, 30 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | 3 | 1 | 4 | 6 | 8 | 15 | 17 |
| Total operating expenses | 3 | 2 | 5 | 8 | 9 | 18 | 19 |
| Operating income | (3) | (2) | (5) | (8) | (9) | (18) | (19) |
| Interest and investment income | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (3) | (2) | (5) | (8) | (9) | (17) | (19) |